Literature DB >> 18579737

Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation.

Benno Roozendaal1, Gustav Schelling, James L McGaugh.   

Abstract

Extensive evidence indicates that stress hormone effects on the consolidation of emotionally influenced memory involve noradrenergic activation of the basolateral complex of the amygdala (BLA). The present experiments examined whether corticotropin-releasing factor (CRF) modulates memory consolidation via an interaction with the beta-adrenoceptor-cAMP system in the BLA. In a first experiment, male Sprague Dawley rats received bilateral infusions of the CRF-binding protein ligand inhibitor CRF(6-33) into the BLA either alone or together with the CRF receptor antagonist alpha-helical CRF(9-41) immediately after inhibitory avoidance training. CRF(6-33) induced dose-dependent enhancement of 48 h retention latencies, which was blocked by coadministration of alpha-helical CRF(9-41), suggesting that CRF(6-33) enhances memory consolidation by displacing CRF from its binding protein, thereby increasing "free" endogenous CRF concentrations. In a second experiment, intra-BLA infusions of atenolol (beta-adrenoceptor antagonist) and Rp-cAMPS (cAMP inhibitor), but not prazosin (alpha(1)-adrenoceptor antagonist), blocked CRF(6-33)-induced retention enhancement. In a third experiment, the CRF receptor antagonist alpha-helical CRF(9-41) administered into the BLA immediately after training attenuated the dose-response effects of concurrent intra-BLA infusions of clenbuterol (beta-adrenoceptor agonist). In contrast, alpha-helical CRF(9-41) did not alter retention enhancement induced by posttraining intra-BLA infusions of either cirazoline (alpha(1)-adrenoceptor agonist) or 8-br-cAMP (cAMP analog). These findings suggest that CRF facilitates the memory-modulatory effects of noradrenergic stimulation in the BLA via an interaction with the beta-adrenoceptor-cAMP cascade, at a locus between the membrane-bound beta-adrenoceptor and the intracellular cAMP formation site. Moreover, consistent with evidence that glucocorticoids enhance memory consolidation via a similar interaction with the beta-adrenoceptor-cAMP cascade, a last experiment found that the CRF and glucocorticoid systems within the BLA interact in influencing beta-adrenoceptor-cAMP effects on memory consolidation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579737      PMCID: PMC2586417          DOI: 10.1523/JNEUROSCI.1336-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  88 in total

1.  Regulation of alpha and beta components of noradrenergic cyclic AMP response in cortical slices.

Authors:  E A Stone; B S McEwen; A S Herrera; K D Carr
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

2.  Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus.

Authors:  P E Sawchenko
Journal:  Brain Res       Date:  1987-02-17       Impact factor: 3.252

3.  Modulating effects of posttraining epinephrine on memory: involvement of the amygdala noradrenergic system.

Authors:  K C Liang; R G Juler; J L McGaugh
Journal:  Brain Res       Date:  1986-03-12       Impact factor: 3.252

4.  Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

Authors:  R J Valentino; S L Foote; G Aston-Jones
Journal:  Brain Res       Date:  1983-07-04       Impact factor: 3.252

Review 5.  Differential involvement of amygdaloid CRH system(s) in the salience and valence of the stimuli.

Authors:  Zul Merali; David Michaud; Judy McIntosh; Pamela Kent; Hymie Anisman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-12       Impact factor: 5.067

6.  17 alpha-alkynyl-11 beta, 17-dihydroxyandrostane derivatives : a new class of potent glucocorticoids.

Authors:  G Teutsch; G Costerousse; R Deraedt; J Benzoni; M Fortin; D Philibert
Journal:  Steroids       Date:  1981-12       Impact factor: 2.668

7.  Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation.

Authors:  Benno Roozendaal; Kristen L Brunson; Brian L Holloway; James L McGaugh; Tallie Z Baram
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-02       Impact factor: 11.205

8.  Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons.

Authors:  J B Aldenhoff; D L Gruol; J Rivier; W Vale; G R Siggins
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

9.  Memory-enhancing effects of posttraining naloxone: involvement of beta-noradrenergic influences in the amygdaloid complex.

Authors:  J L McGaugh; I B Introini-Collison; A H Nagahara
Journal:  Brain Res       Date:  1988-04-12       Impact factor: 3.252

10.  Corticotrophin releasing factor is more potent than some corticotrophin-related peptides in affecting passive avoidance behaviour in rats.

Authors:  A Sahgal; C Wright; J A Edwardson; A B Keith
Journal:  Neurosci Lett       Date:  1983-03-28       Impact factor: 3.046

View more
  54 in total

1.  The central amygdala nucleus via corticotropin-releasing factor is necessary for time-limited consolidation processing but not storage of contextual fear memory.

Authors:  Matthew W Pitts; Lorey K Takahashi
Journal:  Neurobiol Learn Mem       Date:  2010-11-17       Impact factor: 2.877

2.  Endocannabinoid signaling within the basolateral amygdala integrates multiple stress hormone effects on memory consolidation.

Authors:  Piray Atsak; Daniela Hauer; Patrizia Campolongo; Gustav Schelling; Raquel V Fornari; Benno Roozendaal
Journal:  Neuropsychopharmacology       Date:  2014-12-30       Impact factor: 7.853

3.  Independent roles of beta-adrenergic and glucocorticoid receptors in systemic and pulmonary effects of ozone.

Authors:  Andres R Henriquez; Samantha J Snow; Mette C Schladweiler; Colette N Miller; Urmila P Kodavanti
Journal:  Inhal Toxicol       Date:  2020-05-04       Impact factor: 2.724

4.  Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice.

Authors:  M Qin; Z Xia; T Huang; C B Smith
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

Review 5.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

6.  Contrasting effects of pretraining, posttraining, and pretesting infusions of corticotropin-releasing factor into the lateral amygdala: attenuation of fear memory formation but facilitation of its expression.

Authors:  Koichi Isogawa; David E A Bush; Joseph E LeDoux
Journal:  Biol Psychiatry       Date:  2012-10-01       Impact factor: 13.382

Review 7.  Molecular brake pad hypothesis: pulling off the brakes for emotional memory.

Authors:  Annie Vogel-Ciernia; Marcelo A Wood
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

Review 8.  Emotional modulation of the synapse.

Authors:  Jayme R McReynolds; Christa K McIntyre
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

9.  Early-life stress disrupts attachment learning: the role of amygdala corticosterone, locus ceruleus corticotropin releasing hormone, and olfactory bulb norepinephrine.

Authors:  Stephanie Moriceau; Kiseko Shionoya; Katherine Jakubs; Regina M Sullivan
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

Review 10.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.